Keith Killian
Impact in
- Neurology top 10%
- Neuroblastoma Research and Treatments
- Myasthenia Gravis and Thymoma
-
- Glioma Diagnosis and Treatment
Papers in
-
- Advanced biosensing and bioanalysis techniques 2
- Renal and related cancers 2
- Oncology 8
- Lung Cancer Research Studies 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Paul S. Meltzer (9 shared papers)Maria J. Merino (2 shared papers)Martha Quezado (2 shared papers)Katherine E. Warren (1 shared paper)Miia Suuriniemi (1 shared paper)Mark Ming‐Cheng Cheng (2 shared papers)David Geho (2 shared papers)Emanuel F. Petricoin (2 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Biomaterials (1 paper)Cell Death and Disease (1 paper)Frontiers in Genetics (1 paper)Human Pathology (1 paper)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Keith Killian
24 papers receiving 441 citations
Peers
Comparison fields: 5 of 75
- Neurology 117
- Genetics 65
- Oncology 125
- Molecular Biology 203
- Endocrinology, Diabetes and Metabolism 45
Countries citing papers authored by Keith Killian
This map shows the geographic impact of Keith Killian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Killian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Killian more than expected).
Fields of papers citing papers by Keith Killian
This network shows the impact of papers produced by Keith Killian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Killian. The network helps show where Keith Killian may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Killian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 79 | |
| 2 | 2012 | 58 | |
| 3 | 2011 | 56 | |
| 4 | 2006 | 51 | |
| 5 | 2018 | 36 | |
| 6 | 2006 | 29 | |
| 7 | 2012 | 27 | |
| 8 | 2022 | 27 | |
| 9 | 2014 | 26 | |
| 10 | 2013 | 21 | |
| 11 | 2020 | 6 | |
| 12 | 2017 | 5 | |
| 13 | 2013 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2020 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2018 | 2 | |
| 18 | 2016 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2015 | 1 |
About Keith Killian
Keith Killian is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 24 papers that have together received 448 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Neuroblastoma Research and Treatments (4 papers), Lung Cancer Research Studies (3 papers), Prostate Cancer Treatment and Research (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Renal and related cancers (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Neurology (117 citations), Genetics (65 citations), Oncology (125 citations), Molecular Biology (203 citations) and Endocrinology, Diabetes and Metabolism (45 citations). Keith Killian has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Paul S. Meltzer, Maria J. Merino, Martha Quezado, Katherine E. Warren, Miia Suuriniemi, Mark Ming‐Cheng Cheng, David Geho, Emanuel F. Petricoin, Paul C. Herrmann and Mauro Ferrari. Their work appears in journals such as Journal of Clinical Oncology, Biomaterials, Cell Death and Disease, Frontiers in Genetics and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.